Technological aspects of optimization of production process of the drug “SINARTA” for parenteral administration
DOI:
https://doi.org/10.24959/uekj.16.4Keywords:
technological process, aseptic production, sterile filtration, eventual sterilization in the impermeable packing, preparation SINARTA for parenteral introductionAbstract
The technological aspects of optimization of production preparation SINARTA for parenteral introduction have been carried out. It is set during experiment, that a production comes true in aseptic terms from sterile initial substances and materials with the use of sterile filtration for an ampoule A and eventual thermal sterilization for the ampoule of B. Reasonable technology of preparation SINARTA for parenteral introduction provides the indexes of quality concordantly pharmacopeias requirements and specifications.
References
Аннефельд М. Новые данные о глюкозамина сульфате при остеоартрите / М. Аннефельд // Науч.-практ. ревматол. – 2005. – № 4. – С. 76-80.
Бойко Я. Є. Сучасне лікування ювенільного ревматоїдного артриту: ера біологічної терапії / Я. Є. Бойко // Дитячий лікар. – 2012. – № 1-2. – С. 14-24.
Волох Д. С. Місце нестероїдних протизапальних засобів на фармацевтичному ринку України та їх роль при лікування захворювань кістково-м’язової системи / Д. С. Волох, В. В. Довжук, В. І. Чуєшов / Актуальні питання фармацевтичної та медичної науки та практики: Зб. наук. статей. – Вип. ХV. – Запоріжжя, 2006. – Т. 2. – С. 370-377.
Волох Д. С. Раціональне застосування нестероїдних протизапальних лікарських засобів у ревматології / Д. С. Волох, В. В. Довжук, В. І. Чуєшов // Запорожский мед. журн. – 2009. – Т. 11, № 3. – С. 57-58.
Egger М. Bias in meta analysis detected bi a simple, graphical test / М. Egger, G. Davey Smith, М. Scheneider, C. Minder // BMJ. – 1997. – Vol. 315. – Р. 629-634.
McAlindon T. E. Glucosamine and chondroitin for treatment of osteoarthritis: a ssystematic quality assessment and meta-analysis / T. E. McAlindon, M. P. La Valley, J. P. Gulin, D. T. Felson // JAMA. – 2000. – Vol. 283. – Р. 1469-1475.
Project Management Methodologies Explained [Электронный ресурс] / PROGECT SMART 2013 – Режим доступа: https://www. projectsmart.co.uk/ project-managementmethodology-explained.Php
Sterne J. A. Systematic reviews in health care: investigating and dealing with publicacion and other biases in meta analysis / J. A. Sterne, М. Egger, G. D. Smith // BMJ. – 2001. – Vol. 323. – Р. 101-105.
Toward Higher QA: From Parametric Release of Sterile Parenteral Products to PAT for Other Pharmaceutical Dosage Forms // PDA J. Pharm. Sci. Technol. – 2012. – Vol. 66 (4). – P. 371-391.
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-seventh Report. Geneva, World Health Organization, 2003 (WHO Technical Report Series № 908). – Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals. – P. 99-112.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
